Functional Immune Reconstitution by Interleukin-2 Adjunctive Therapy for HIV/Mycobacterial Co-infection.
Jan
J
Heyckendorf
Sven Philip
SP
Aries
Ulf
U
Greinert
Elvira
E
Richter
Holger
H
Schultz
Christoph
C
Lange
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D002626:Chemistry, Pharmaceutical; D017024:Chemotherapy, Adjuvant; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D016867:Immunocompromised Host; D007376:Interleukin-2 / Q000008:administration & dosage*; D008297:Male; D009159:Mycobacteriaceae / Q000302:isolation & purification*; D009165:Mycobacterium Infections, Nontuberculous / Q000150:complications / Q000188:drug therapy*
D007376:Interleukin-2
HIV; IL-2; Mycobacterium tilburgii; immunotherapy